Results 1 to 10 of about 407,104 (349)

Upstream Regulators of Fibroblast Growth Factor 23 [PDF]

open access: yesFrontiers in Endocrinology, 2021
Fibroblast growth factor 23 (FGF23) has been described as an important regulator of mineral homeostasis, but has lately also been linked to iron deficiency, inflammation, and erythropoiesis. FGF23 is essential for the maintenance of phosphate homeostasis
Danielle M. A. Ratsma   +2 more
doaj   +3 more sources

Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population [PDF]

open access: yesJournal of Cachexia, Sarcopenia and Muscle
Background Sarcopenia is defined as the loss of muscle mass, strength, and/or performance. It is strongly associated with all‐cause mortality. Fibroblast growth factor 23 (FGF23) is markedly elevated in patients with chronic kidney disease, especially ...
Limy Wong   +5 more
doaj   +2 more sources

Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia [PDF]

open access: yesEndocrinology and Metabolism
Fibroblast growth factor 23 (FGF23) is a pivotal humoral factor for the regulation of serum phosphate levels and was first identified in patients with autosomal dominant hypophosphatemic rickets and tumor-induced osteomalacia (TIO), the most common form ...
Nobuaki Ito, Naoko Hidaka, Hajime Kato
doaj   +2 more sources

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway

open access: goldKidney International Reports, 2017
Joseph Wang   +6 more
doaj   +2 more sources

Deletion of cardiac fibroblast growth factor-23 beneficially impacts myocardial energy metabolism in left ventricular hypertrophy. [PDF]

open access: diamondNPJ Metab Health Dis
Latic N   +13 more
europepmc   +3 more sources

High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis

open access: yesFrontiers in Medicine, 2023
IntroductionA negative association between C-terminal fibroblast growth factor 23 (cFGF23) and hemoglobin (Hb) levels has been reported in patients with predialysis chronic kidney disease.
Yu-Wei Fang   +9 more
doaj   +1 more source

Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation. [PDF]

open access: goldJ Cardiovasc Dev Dis
Yared W   +10 more
europepmc   +3 more sources

Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease [PDF]

open access: yes, 2012
Background: Uremic solute concentration increases as Glomerular Filtration Rate (GFR) declines. Weak associations were demonstrated between estimated GFR (eGFR) and the concentrations of several small water-soluble and protein-bound uremic solutes ...
Barreto, Daniela V   +9 more
core   +11 more sources

Home - About - Disclaimer - Privacy